Trinity Capital Inc. Stock Price, News & Analysis

Trinity Capital Inc. (NASDAQ: TRIN) has committed $40 million in growth capital to Impress, a leading European orthodontic chain specializing in invisible aligners. The funding is part of a larger $117 million funding round and will support Impress's expansion plans, including opening 20 new clinics across Europe. Based in Barcelona, Impress operates a network of clinics serving over 250,000 patients annually and has recently acquired DrSmile to strengthen its market position in Europe.

Trinity Capital (Nasdaq: TRIN) announced its board has authorized a $30 million stock repurchase program running until November 7, 2025. The company may repurchase its common stock in the open market, subject to Rule 10b-18 constraints. The board initiated this program believing macroeconomic pressures may cause stock undervaluation relative to company performance and peers. The repurchases will comply with the Investment Company Act of 1940. While Trinity hasn't yet started repurchasing shares, management can now act when deemed advantageous to shareholders.

Trinity Capital (TRIN) reported strong Q3 2024 financial results with record total investment income of $61.8 million, up 33.2% year-over-year, and record net investment income of $29.4 million ($0.54 per share). The company achieved a 16.2% return on average equity and maintained a net asset value of $756.8 million ($13.13 per share). Total gross investment commitments reached $629.2 million, with $459.0 million funded across new and existing portfolio companies. The company's total platform assets under management increased to $2.0 billion, up 54% year-over-year, marking its 19th consecutive quarter of consistent or increased regular dividend.

Trinity Capital (Nasdaq: TRIN) has successfully closed a $142.5 million private notes offering of unsecured Series A Notes. The offering, which was oversubscribed from the initial $100 million target, consists of three tranches with different maturities and interest rates: $55.5 million at 7.54% due 2027, $73.0 million at 7.60% due 2028, and $14.0 million at 7.66% due 2029. The company plans to use the proceeds to support ongoing investment activities and grow its diversified lending platform.

Trinity Capital Inc. (NASDAQ: TRIN) has committed $40 million in growth capital to Beam Benefits, a digitally native employee benefits company. Beam, founded in 2012, offers a comprehensive platform for ancillary benefits, including dental, vision, life, disability, and supplemental health coverage. The funding will enable Beam to scale operations and fund growth initiatives.

Jack McNamara, Director of Tech Lending at Trinity, praised Beam's success in changing how small businesses access and offer ancillary benefits. Alex Frommeyer, CEO and co-founder of Beam Benefits, expressed excitement about the partnership, stating that the funds will help propel Beam's modernization of employee benefits by building tools for brokers and partner benefits providers across the US.

Trinity Capital Inc. (Nasdaq: TRIN) reported a record-breaking third quarter in 2024, originating $635 million in investments and funding $459 million. This brings the total new commitments for the first three quarters of 2024 to $1.2 billion. The Q3 funding breakdown includes $406 million in secured loans, $39 million in equipment financings, and $14 million in warrant and equity investments.

Key highlights for Q3 include:

• $255 million funded to 11 new portfolio companies
• $202 million to 20 existing portfolio companies
• $198 million received from repayments and exits

For the first three quarters of 2024, Trinity funded approximately $933 million in total investments and received $527 million from repayments and exits.

Trinity Capital Inc. (Nasdaq: TRIN), a provider of financial solutions to growth-stage companies, has announced a time change for its third quarter 2024 earnings conference call. The call will now take place at 8:00 a.m. PT (11:00 a.m. ET) on Wednesday, October 30, 2024, one hour earlier than previously scheduled. The company will release its Q3 2024 financial results before market open on the same day.

To participate in the call, investors can dial (800) 267-6316 or (203) 518-9783 internationally, referencing Conference ID: TRINQ324. A taped replay will be available until November 6, 2024, accessible by dialing (800) 839-1180 or (402) 220-0400. Additionally, a live webcast will be available on Trinity's investor relations website, with a replay accessible for 90 days following the call.

Trinity Capital Inc. (Nasdaq: TRIN), a provider of financial solutions to growth-stage companies, has announced the release date for its third quarter 2024 financial results. The results will be released before market open on Wednesday, October 30, 2024. Following the release, Trinity will host a conference call at 9:00 a.m. PT (12:00 p.m. ET) to discuss the results.

Investors can join the call by dialing (800) 267-6316 or (203) 518-9783 internationally, referencing Conference ID: TRINQ324. A taped replay will be available until November 6, 2024, accessible by dialing (800) 839-1180 or (402) 220-0400. Additionally, a live webcast of the call will be available on the company's investor relations website, with a replay accessible for 90 days following the conference.

Centivo, a healthcare company focused on making quality healthcare more affordable, has secured $75 million in equity and debt financing. The funding includes participation from new strategic investors Cone Health Ventures and MemorialCare Innovation Fund, as well as existing financial investors. This capital will help Centivo accelerate its mission of providing accessible and affordable healthcare to working families.

Centivo's three-part solution includes: (1) an advanced primary care centered model with Centivo Care, their in-house virtual primary care practice, (2) direct contracts with leading accountable care organizations in 18 major markets, and (3) a transparent, tech-enabled member engagement and plan administration platform. In 2023, Centivo's health plans achieved a 71% reduction in member out-of-pocket costs while typically saving employers 15% or more and increasing utilization of primary and specialty care.